| Factor Information | |
|---|---|
| Data ID | 430 |
| Factor | neurocognitive deficits |
| Description | Children with congenital heart disease (CHD) and adults with acquired heart disease are at an increased risk of neurocognitive impairment. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | to determine the prevalence of self-reported neurocognitive impairment and its risk factors in the adult congenital heart disease (ACHD) population. |
| p Value | <0.01 |
| Conclusion | There is a high prevalence of ACHD patients with significant self-perceived neurocognitive deficits. This difference was most striking in the domains of math, attention, and memory. Simple screening questionnaires may help identify those patients at high risk and allow for timely and appropriate referral for formal neurocognitive evaluation, diagnosis, and therapy. |
| Risk Factor | risk factor (article mentioned) |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 30066452 |
| Year | 2018 |
| Title | Identifying self‐reported neurocognitive deficits in the adult with congenital heart disease using a simple screening tool |
| Sample | ||
|---|---|---|
| Population | Adults (337 ACHD patients) | |
| Source | questionnaires | |
| Region | Wisconsin,USA | |
| Method | screening | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | cardiac surgeries | |
| Group | self-reported significant neurocognitive deficits(Treatment) | reported no or minor neurocognitive dificits(Control) |
| Number | 18(total:116)(18 completed formal neurocognitive testing) | 2(total:221)(2 completed formal neurocognitive testing) |
| Age | 31 ± 10.8 years | 30 ± 10.0 years |
| Gender (Male: Female) | 62:54 | 108:113 |
| Marker Level | 0.9 | 0.1 |
